Amgen/ US0311621009 /
| 11/29/2021 4:02:58 PM | Chg. +1.75 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 202.99USD | +0.87% | 8,343 Turnover: 1.69 mill. |
-Bid Size: - | -Ask Size: - | 113.68 bill.USD | 3.17% | 16.28 |
Newsfile Corp
11/23
A Strong Vibrant Life Sciences Sector, Pricing Regulations and Diversity, Equity and Inclusion Top P...
Newsfile Corp
11/23
Les priorités absolues de Cole Pinnow, nouveau président du conseil d'administration de MNC, sont la...
GlobeNewswire
11/23
Plotly and Mila Announce Partnership to Combine Data Visualization and AI Expertise
GlobeNewswire
11/22
Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference
GlobeNewswire
11/18
All-Digital AIDS Walk Los Angeles 2021 Continues to Fight the HIV/AIDS Epidemic in Los Angeles Count...
GlobeNewswire
11/15
Recludix Pharma Launches with $60 Million Series A to Support Innovative Platform to Discover and De...
GlobeNewswire
11/10
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
GlobeNewswire
11/8
Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors
GlobeNewswire
11/5
Guild Education and OneTen Partner to Expand Access to Education and Upskilling for Black Talent Acr...
GlobeNewswire
11/5
Coherus BioSciences Announces CMS Has Extended Enhanced Medicare Reimbursement for UDENYCA® in the 3...
GlobeNewswire
11/4
CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
11/3
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
GlobeNewswire
11/3
Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Exe...